Back to Search Start Over

Rhabdomyoblastic Differentiation in Head and Neck Malignancies Other Than Rhabdomyosarcoma

Authors :
Bishop, J.A.
Thompson, L.D.
Cardesa, A.
Barnes, L.
Lewis, J.S., Jr.
Triantafyllou, A.
Hellquist, H.
Stenman, G.
Hunt, J.L.
Williams, M.D.
Slootweg, P.J.
Devaney, K.O.
Gnepp, D.R.
Wenig, B.M.
Rinaldo, A.
Ferlito, A.
Bishop, J.A.
Thompson, L.D.
Cardesa, A.
Barnes, L.
Lewis, J.S., Jr.
Triantafyllou, A.
Hellquist, H.
Stenman, G.
Hunt, J.L.
Williams, M.D.
Slootweg, P.J.
Devaney, K.O.
Gnepp, D.R.
Wenig, B.M.
Rinaldo, A.
Ferlito, A.
Source :
Head and Neck Pathology; 507; 518; 1936-055X; 4; 9; ~Head and Neck Pathology~507~518~~~1936-055X~4~9~~
Publication Year :
2015

Abstract

Contains fulltext : 152674.pdf (publisher's version ) (Closed access)<br />Rhabdomyosarcoma is a relatively common soft tissue sarcoma that frequently affects children and adolescents and may involve the head and neck. Rhabdomyosarcoma is defined by skeletal muscle differentiation which can be suggested by routine histology and confirmed by immunohistochemistry for the skeletal muscle-specific markers myogenin or myoD1. At the same time, it must be remembered that when it comes to head and neck malignancies, skeletal muscle differentiation is not limited to rhabdomyosarcoma. A lack of awareness of this phenomenon could lead to misdiagnosis and, subsequently, inappropriate therapeutic interventions. This review focuses on malignant neoplasms of the head and neck other than rhabdomyosarcoma that may exhibit rhabdomyoblastic differentiation, with an emphasis on strategies to resolve the diagnostic dilemmas these tumors may present. Axiomatically, no primary central nervous system tumors will be discussed.

Details

Database :
OAIster
Journal :
Head and Neck Pathology; 507; 518; 1936-055X; 4; 9; ~Head and Neck Pathology~507~518~~~1936-055X~4~9~~
Publication Type :
Electronic Resource
Accession number :
edsoai.on1284080072
Document Type :
Electronic Resource